Your browser doesn't support javascript.
loading
Are the current guidelines for identification of myelodysplastic syndrome with germline predisposition strong enough?
Calvete, Oriol; Mestre, Julia; Durmaz, Arda; Gurnari, Carmelo; Maciejewski, Jaroslaw P; Solé, Francesc.
Affiliation
  • Calvete O; Myelodysplastic Syndrome Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Mestre J; Myelodysplastic Syndrome Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Durmaz A; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Ohio, Cleveland, USA.
  • Gurnari C; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Ohio, Cleveland, USA.
  • Maciejewski JP; Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.
  • Solé F; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Ohio, Cleveland, USA.
Br J Haematol ; 201(1): e5-e11, 2023 04.
Article in En | MEDLINE | ID: mdl-36717968
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2023 Document type: Article Affiliation country: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2023 Document type: Article Affiliation country: Spain